1. 2024
  2. THE ANALYSIS OF PRESCRIBING CDK4/6 INHIBITORS FOR PATIENTS WITH BREAST CANCER IN REAL CLINICAL PRACTICE

    Орлова, Р. В., Avramenko, I. V., Андросова, А. В., Топузов, Э. Э., Беляк, Н. П., Кутукова, С. И., Вахитова, А. А. & Глузман, М. И., 2024.

    Research output: Contribution to conferenceAbstractpeer-review

  3. 2020
  4. Russian multicenter experience of using talazoparib in the treatment of patients with brca-associated metastatic breast cancer

    Semiglazova, T. Y., Lubennikova, E. V., Bolotina, L. V., Orlova, R. V., Moiseenko, F. V., Avramenko, I. V., Artemeva, E. V., Borozdina, S. A., Vakhitova, A. A., Volkov, N. M., Ganshina, I. P., Dzhalilova, S. A., Zhukova, L. G., Kasparov, B. S., Kachmazov, A. A., Klimenko, V. V., Kornietskaya, A. L., Meshcheryakov, A. A., Paichadze, A. A., Poltoratsky, A. N. & 3 others, Ryabishina, O. E., Stepanova, M. L. & Imyanitov, E. N., 2020, In: Meditsinskiy Sovet. 2020, 20, p. 143-149 7 p.

    Research output: Contribution to journalArticlepeer-review

  5. 2019

ID: 8973455